BioXcel Therapeutics Inc

BioXcel Therapeutics Inc

BTAI

Get informed when a big investor buys or sells

+ Follow
Market Cap$25.24M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioXcel Therapeutics IncBioXcel Therapeutics Inc-0.1-71%--1
$-1.08

Current Fair Value

205.1% downside

Overvalued by 205.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$25.24 Million
Enterprise Value$108.35 Million
Dividend Yield$- (-)
Earnings per Share$-5.73
Beta0.27
Outstanding Shares12,208,000

Return

Return on Equity71.38%ROE
Return on Assets-221.41%
Return on Invested Capital299.79%

Valuation & Multiples

P/E Ratio-0.12P/E Ratio
PEG-0.16PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.11Price to Book Ratio
Enterprise Value to Revenue159.34
Enterprise Value to EBIT-1.72
Enterprise Value to Net Income-2
Total Debt to Enterprise0.93
Debt to Equity-0.95Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 15, 2026
EPS Estimate
$-0.59
Average shareholder expectation
Revenue Estimate
$381,491
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.42
Average shareholder expectation
Revenue Estimate
$403,315
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %44.57%▲ 19.65%
Total Invested$7.28M▲ 28.45%
Investors Holding40▼ 1.00%

ESG Score

No data

About BioXcel Therapeutics Inc

CEO: Vimal Mehta